Drug · DIN 02266121
SATIVEX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 22, 2026; first marketed June 22, 2005.
- Drug Identification Number (DIN)
- 02266121
- Company (DIN owner)
- Cnx Therapeutics LimitedLondon, United Kingdom
- Schedule
- Prescription
- Dosage form
- Spray (Metered-Dose)
- Route
- Buccal
- Therapeutic class (ATC)
- Cannabinoids N02BG10
- Class
- Human
- Record last updated
- July 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DELTA-9-TETRAHYDROCANNABINOL (CANNABIS SATIVA EXTRACT) | 2.7 MG | ACT |
| CANNABIDIOL (CANNABIS SATIVA EXTRACT) | 2.5 MG | ACT |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 22, 2026: NOC 37965New Drug Submission (NDS) · Administrative: Change in product ownership
- December 17, 2024: NOC 34566New Drug Submission (NDS) · Administrative: Change in manufacturer name
- April 15, 2005: NOC 6433New Drug Submission (NDS)